Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines

Cirrhotic patients with severe thrombocytopenia are at increased risk of bleeding during invasive procedures. The need for preprocedural prophylaxis aimed at reducing the risk of bleeding in cirrhotic patients with thrombocytopenia who undergo scheduled procedures is assessed via the platelet count; however, establishing a minimum threshold considered safe is challenging. A platelet count ≥ 50000/μL is a frequent target, but levels vary by provider, procedure, and specific patient. Over the years, this value has changed several times according to the different guidelines proposed in the literature. According to the latest guidelines, many procedures can be performed at any level of platelet count, which should not necessarily be checked before the procedure. In this review, we aim to investigate and describe how the guidelines have evolved in recent years in the evaluation of the minimum platelet count threshold required to perform different invasive procedures, according to their bleeding risk.

[1]  Ramesh Kumar,et al.  Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease , 2022, World journal of hepatology.

[2]  H. Yoshiji,et al.  Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures , 2022, Advances in Therapy.

[3]  A. de Gottardi,et al.  EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. , 2022, Journal of hepatology.

[4]  J. Thachil,et al.  Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH , 2022, Journal of thrombosis and haemostasis : JTH.

[5]  R. Tateishi,et al.  Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease , 2021, Advances in Therapy.

[6]  G. Su,et al.  AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. , 2021, Gastroenterology.

[7]  H. Maddur,et al.  Avatrombopag Use in Patient With Thromboembolic Risks Listed for Combined Coronary Artery Bypass Grafting and Liver Transplant: A Case Report. , 2021, Transplantation proceedings.

[8]  D. Valla,et al.  Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.

[9]  A. Shenoy,et al.  Thromboelastography and Utility in Hepatology Practice , 2020, Clinical liver disease.

[10]  S. Morjaria,et al.  Rethinking the need for a platelet transfusion threshold of 50 × 109/L for lumbar puncture in cancer patients , 2020, Transfusion.

[11]  S. Flamm,et al.  Thrombocytopenia in Chronic Liver Disease: New Management Strategies. , 2020, Clinics in liver disease.

[12]  W. Zhou,et al.  Coronary artery bypass graft combined with liver transplantation in patients with advanced alcoholic liver cirrhosis: A case report , 2020, Experimental and therapeutic medicine.

[13]  S. N. Sayar Platelet , 2020, Definitions.

[14]  Douglas A. Simonetto,et al.  ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. , 2020, The American journal of gastroenterology.

[15]  J. S. Kim,et al.  Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy , 2019, Gut and liver.

[16]  S. Gamanagatti,et al.  A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures , 2019, Digestive Diseases and Sciences.

[17]  Hannah A. Blair,et al.  Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure , 2019, Drugs.

[18]  S. Caldwell,et al.  Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists , 2019, Hepatology communications.

[19]  S. Caldwell,et al.  AGA Clinical Practice Update: Coagulation in Cirrhosis. , 2019, Gastroenterology.

[20]  K. Simon,et al.  Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2) , 2019, Hepatology.

[21]  A. Saraya,et al.  Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding , 2019, Digestive Diseases and Sciences.

[22]  S. Agarwal,et al.  Real-Time Ultrasound-Guided Paracentesis by Radiologists: Near Zero Risk of Hemorrhage without Correction of Coagulopathy. , 2019, Journal of vascular and interventional radiology : JVIR.

[23]  P. Braz-Silva,et al.  Bleeding during and after dental extractions in patients with liver cirrhosis. , 2018, International journal of oral and maxillofacial surgery.

[24]  E. Giannini,et al.  Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients. , 2018, Annals of hepatology.

[25]  T. Hassanein,et al.  Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. , 2018, Gastroenterology.

[26]  H. Büller,et al.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference , 2018, Thrombosis and Haemostasis.

[27]  W. Middleton,et al.  Bleeding Complications After Percutaneous Liver Biopsy: Do Subcapsular Lesions Pose a Higher Risk? , 2018, AJR. American journal of roentgenology.

[28]  L. Cavanna,et al.  Thoracentesis in advanced cancer patients with severe thrombocytopenia: Ultrasound guide improves safety and reduces bleeding risk , 2018, The clinical respiratory journal.

[29]  M. Z. Ansari,et al.  A Rare Etiology of Severe Thrombocytopenia in Patient with Chronic Liver Disease. , 2018, The Journal of the Association of Physicians of India.

[30]  P. Rebulla,et al.  Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Tilg,et al.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) , 2017, Wiener klinische Wochenschrift.

[32]  H. J. Lee,et al.  Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. , 2017, Clinical radiology.

[33]  M. Peck‐Radosavljevic Thrombocytopenia in chronic liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[34]  J. Hoofnagle,et al.  Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience , 2017, Alimentary pharmacology & therapeutics.

[35]  A. Andriulli,et al.  Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. , 2017, European journal of internal medicine.

[36]  Jonathan P. Kerr,et al.  Guidelines for the use of platelet transfusions , 2017, British journal of haematology.

[37]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[38]  S. Carossa,et al.  Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters. , 2017, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[39]  C. Zauner,et al.  Coagulation parameters and major bleeding in critically ill patients with cirrhosis , 2016, Hepatology.

[40]  A. Andriulli,et al.  Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[41]  R. Montalti,et al.  Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial , 2016, Hepatology.

[42]  John A. Evans,et al.  The management of antithrombotic agents for patients undergoing GI endoscopy. , 2016, Gastrointestinal endoscopy.

[43]  R. D. de Knegt,et al.  Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies , 2015, Drugs.

[44]  P. Kamath,et al.  Bleeding Rate for Ultrasound‐Guided Paracentesis in Thrombocytopenic Patients , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[45]  A. Gialeraki,et al.  Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility , 2015, Asian journal of transfusion science.

[46]  Stephanie A. Smith,et al.  How it all starts: Initiation of the clotting cascade , 2015, Critical reviews in biochemistry and molecular biology.

[47]  S. Kleinman,et al.  Platelet transfusion: a systematic review of the clinical evidence , 2015, Transfusion.

[48]  Ashutosh Kumar Singh,et al.  The safety of ultrasound guided central venous cannulation in patients with liver disease , 2015, Saudi journal of anaesthesia.

[49]  Benjamin Djulbegovic,et al.  Platelet Transfusion: A Clinical Practice Guideline From the AABB , 2015, Annals of Internal Medicine.

[50]  M. Trivella,et al.  Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. , 2015, The Cochrane database of systematic reviews.

[51]  Esther S. Kim,et al.  Lusutrombopag: First Global Approval , 2015, Drugs.

[52]  J. Barsuk,et al.  Thoracentesis outcomes: a 12-year experience , 2014, Thorax.

[53]  J. Puchalski Thoracentesis and the risks for bleeding: a new era , 2014, Current opinion in pulmonary medicine.

[54]  Amy Wang,et al.  Routine laboratory testing before endoscopic procedures. , 2014, Gastrointestinal endoscopy.

[55]  N. Dunbar,et al.  Transfusion guidelines: when to transfuse. , 2013, Hematology. American Society of Hematology. Education Program.

[56]  S. Caldwell,et al.  Coagulation in liver disease: a guide for the clinician. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[57]  T. Atwell,et al.  Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. , 2013, Chest.

[58]  P. Kamath,et al.  Management of antithrombotic therapy in patients undergoing invasive procedures. , 2013, The New England journal of medicine.

[59]  B. Runyon,et al.  Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012 , 2013, Hepatology.

[60]  M. Poca,et al.  Transfusion strategies for acute upper gastrointestinal bleeding. , 2013, The New England journal of medicine.

[61]  R. Fanelli,et al.  Adverse events of upper GI endoscopy. , 2012, Gastrointestinal endoscopy.

[62]  A. Alves,et al.  Postoperative bleeding after dental extraction in liver pretransplant patients. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[63]  Donald L. Miller,et al.  Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. , 2009, Journal of vascular and interventional radiology : JVIR.

[64]  O. Senn,et al.  Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia , 2011, Transfusion.

[65]  Maitray D. Patel,et al.  Abnormal preprocedural international normalized ratio and platelet counts are not associated with increased bleeding complications after ultrasound-guided thoracentesis. , 2011, AJR. American journal of roentgenology.

[66]  Guang-shun Yang,et al.  Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases , 2011, World Journal of Surgery.

[67]  I. Sheen,et al.  MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. , 2011, World journal of gastroenterology.

[68]  S. Maithel,et al.  Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. , 2011, Journal of the American College of Surgeons.

[69]  William M. Lee,et al.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  E. Giannini,et al.  Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[71]  F. Berthier,et al.  Predictive factors of bleeding related to post‐banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case‐control study , 2010, Alimentary pharmacology & therapeutics.

[72]  S. Basili,et al.  The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. , 2010, European journal of internal medicine.

[73]  A. Tripodi The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No. , 2010, European journal of internal medicine.

[74]  B. Spiess Platelet transfusions: the science behind safety, risks and appropriate applications. , 2010, Best practice & research. Clinical anaesthesiology.

[75]  Jeffrey McCullough,et al.  Dose of prophylactic platelet transfusions and prevention of hemorrhage. , 2010, The New England journal of medicine.

[76]  S. Trerotola,et al.  Large-bore tunneled central venous catheter insertion in patients with coagulopathy. , 2010, Journal of vascular and interventional radiology : JVIR.

[77]  K. R. Prasad,et al.  Predictors of blood transfusion requirement in elective liver resection. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[78]  J. Mössner,et al.  Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis , 2010, BMC gastroenterology.

[79]  S. Curley,et al.  Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. , 2010, Surgery.

[80]  S. Ammar Management of complicated umbilical hernias in cirrhotic patients using permanent mesh: randomized clinical trial , 2010, Hernia.

[81]  J. Madariaga,et al.  Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child–Pugh classification in predicting outcome , 2010, Surgical Endoscopy.

[82]  A. Muneer,et al.  Laparoscopic Cholecystectomy in Cirrhotic Patients , 2009, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

[83]  G. Chau,et al.  Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End-Stage Liver Disease Score , 2009, World Journal of Surgery.

[84]  F. Carrilho,et al.  A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[85]  A. de Gottardi,et al.  Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[86]  R. Makuch,et al.  Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[87]  R. Nelson,et al.  Liver biopsy , 2009, Hepatology.

[88]  J. Eikenboom,et al.  The clinical impact of platelet refractoriness: correlation with bleeding and survival , 2008, Transfusion.

[89]  M. Manns,et al.  Thrombocytopenia associated with chronic liver disease. , 2008, Journal of hepatology.

[90]  L. Oğuzkurt,et al.  US-guided placement of central vein catheters in patients with disorders of hemostasis. , 2008, European journal of radiology.

[91]  Matthew S. Johnson,et al.  Time to hemostasis after traction removal of tunneled cuffed central venous catheters. , 2007, Journal of vascular and interventional radiology : JVIR.

[92]  A. Loh,et al.  Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity? , 2007, Journal of pediatric surgery.

[93]  S. Kubo,et al.  Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. , 2007, Hepato-gastroenterology.

[94]  M. Toungouz,et al.  GUIDELINES FOR THE TRANSFUSION OF PLATELETS , 2007, Acta clinica Belgica.

[95]  P. Mannucci,et al.  Thrombin generation in patients with cirrhosis: The role of platelets , 2006, Hepatology.

[96]  E. D. da Silveira Outcome of cirrhotic patients undergoing cholecystectomy: Applying Bayesian analysis in gastroenterology , 2006, Journal of gastroenterology and hepatology.

[97]  M. Ma,et al.  Should bleeding tendency deter abdominal paracentesis? , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[98]  E. DeMaria,et al.  Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients , 2005, Hernia.

[99]  J. Prieto,et al.  The Role of Thrombopoietin in the Thrombocytopenia of Patients with Liver Cirrhosis , 2005, The American Journal of Gastroenterology.

[100]  M. Bilodeau,et al.  Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease , 2005, Alimentary pharmacology & therapeutics.

[101]  William M. Lee,et al.  Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. , 2004, Controlled clinical trials.

[102]  P. Kamath,et al.  Performance standards for therapeutic abdominal paracentesis , 2004, Hepatology.

[103]  S. Body,et al.  Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.

[104]  B. Runyon Management of adult patients with ascites due to cirrhosis , 2004, Hepatology.

[105]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[106]  Guidelines for the use of platelet transfusions , 2003, British journal of haematology.

[107]  K. Ahrar,et al.  Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. , 2003, Journal of vascular and interventional radiology : JVIR.

[108]  J. Wong,et al.  Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma , 2003, The British journal of surgery.

[109]  H. Sørensen,et al.  Thirty‐day case fatality after nephrectomy in patients with liver cirrhosisA Danish population‐based cohort study , 2003, Scandinavian journal of urology and nephrology.

[110]  C. Begley,et al.  Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. , 2002, Blood.

[111]  G. Demetri,et al.  Targeted approaches for the treatment of thrombocytopenia. , 2001, The oncologist.

[112]  H. Vilstrup,et al.  Postoperative mortality in patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish nationwide cohort study , 2001, BJU international.

[113]  J. James,et al.  A Novel Approach to the Assessment of Variations in the Human Platelet Count , 2000, Thrombosis and Haemostasis.

[114]  P. Thampanitchawong,et al.  Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.

[115]  J. Vozenilek,et al.  Laparoscopic cholecystectomy in cirrhotic patients. , 1998, Journal of the American College of Surgeons.

[116]  A. Gangl,et al.  Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? , 1997, Journal of hepatology.

[117]  C. Ray,et al.  Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. , 1997, Radiology.

[118]  T. Pilgram,et al.  Evaluation of coagulation tests as predictors of angiographic bleeding complications. , 1996, Radiology.

[119]  P. Clavien,et al.  Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation , 1994, Annals of surgery.

[120]  E. Christensen,et al.  Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study , 1994 .

[121]  E. Christensen,et al.  Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). , 1994, Journal of hepatology.

[122]  M. Hart,et al.  Central venous catheterization in patients with coagulopathy. , 1992, Archives of surgery.

[123]  P. Toy,et al.  Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. , 1990, American journal of clinical pathology.

[124]  M. Banaji,et al.  The risk of bleeding after percutaneous liver biopsy: relation to platelet count. , 1982, Journal of clinical gastroenterology.

[125]  K. Ewe,et al.  [The bleeding time after liver biopsy does not correlate with peripheral coagulation factors]. , 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.

[126]  D. Zimmon,et al.  The portal pressure-blood volume relationship in cirrhosis 1 , 1974, Gut.

[127]  J. Boyer,et al.  Effect of plasma-volume expansion on portal hypertension. , 1966, The New England journal of medicine.

[128]  R. Aster Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.